Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1995 Sep 1;153(5):545–552.

Fetal tissue transplantation and abortion decisions: a survey of urban women.

D K Martin 1, H Maclean 1, F H Lowy 1, J I Williams 1, E V Dunn 1
PMCID: PMC1487409  PMID: 7641152

Abstract

OBJECTIVE: To describe women's attitudes and predicted behaviour regarding the potential for fetal tissue transplantation (FTT) to influence abortion decisions. DESIGNS: Self-administered questionnaire survey by mail. SETTING: Academic family practice in Toronto. PARTICIPANTS: Random sample of 475 women 18 to 40 years of age selected from the family practice registry of an urban teaching hospital. Family physicians were blind to their patients' participation, and investigators were blind to the subjects' identity. Forty questionnaires were undeliverable. Of the remaining 435, 272 (62.5%) were completed. Six of the women were over 40 years of age or did not indicate their age and were excluded, which left 266 (61.1%) questionnaires for analysis. OUTCOME MEASURES: Number of women who would (a) be more likely to have an abortion if they could donate tissue for FTT and (b) feel better or worse about choosing abortion if FTT were an option, and open-ended comments about the potential for FTT to influence abortion decisions. RESULTS: Of the 266 respondents 32 (12.0%) reported that they would be more likely to have an abortion if they could donate tissue for FTT, 178 (66.9%) stated that they would not be more likely to do so, and 56 (21.1%) were uncertain. Of the 122 who indicated that they would consider an abortion if they were pregnant, 21 (17.2%) stated that they would be more likely to have an abortion if they could donate tissue for FTT, 77 (63.1%) replied that they would not be more likely to do so, and 24 (19.7%) were uncertain. The women 25 to 33 years of age were more likely to be influenced by FTT than the younger or older women, and the women 18 to 24 years were more uncertain about the influence of FTT on abortion decisions than the older women. In written responses some of the women felt that FTT might make abortion decisions easier; many were troubled that FTT might be used to justify a morally problematic abortion decision and felt that FTT should not be used to justify abortion. CONCLUSION: The data, the first of their kind gathered from from women, suggest that some women's abortion decisions may be influenced by the option to donate tissue for FTT. Further research is necessary to explore the mechanism of influence.

Full text

PDF
550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson F., Glasier A., Ross J., Baird D. T. Attitudes of women to fetal tissue research. J Med Ethics. 1994 Mar;20(1):36–40. doi: 10.1136/jme.20.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Annas G. J., Elias S. The politics of transplantation of human fetal tissue. N Engl J Med. 1989 Apr 20;320(16):1079–1082. doi: 10.1056/NEJM198904203201610. [DOI] [PubMed] [Google Scholar]
  3. Barry Robert, Kesler Darrel. Pharaoh's magicians: the ethics and efficacy of human fetal tissue transplants. Thomist. 1990 Oct;54(4):575–607. doi: 10.1353/tho.1990.0000. [DOI] [PubMed] [Google Scholar]
  4. Bracken M. B., Hachamovitch M., Grossman G. Correlates of repeat induced abortions. Obstet Gynecol. 1972 Dec;40(6):816–825. [PubMed] [Google Scholar]
  5. Fine A. Transplantation of fetal cells and tissue: an overview. CMAJ. 1994 Nov 1;151(9):1261–1268. [PMC free article] [PubMed] [Google Scholar]
  6. Freed C. R., Breeze R. E., Rosenberg N. L., Schneck S. A., Kriek E., Qi J. X., Lone T., Zhang Y. B., Snyder J. A., Wells T. H. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med. 1992 Nov 26;327(22):1549–1555. doi: 10.1056/NEJM199211263272202. [DOI] [PubMed] [Google Scholar]
  7. Henshaw S. K., Silverman J. The characteristics and prior contraceptive use of U.S. abortion patients. Fam Plann Perspect. 1988 Jul-Aug;20(4):158–168. [PubMed] [Google Scholar]
  8. Hillebrecht J. M. Regulating the clinical uses of fetal tissue. A proposal for legislation. J Leg Med. 1989 Jun;10(2):269–322. doi: 10.1080/01947648909513574. [DOI] [PubMed] [Google Scholar]
  9. Jones D. Hospital's decision to pursue fetal transplantation upsets antiabortionists. CMAJ. 1990 Jun 1;142(11):1274-5, 1277. [PMC free article] [PubMed] [Google Scholar]
  10. Kearney W., Vawter D. E., Gervais K. G. Fetal tissue research and the misread compromise. Hastings Cent Rep. 1991 Sep-Oct;21(5):7–12. [PubMed] [Google Scholar]
  11. Martin D. K. Foetal tissue transplantation research: a Canadian policy analysis. Health Law Can. 1992;13(1):132–141. [PubMed] [Google Scholar]
  12. Mullen M. A., Williams J. I., Lowy F. H. Transplantation of electively aborted human fetal tissue: physicians' attitudes. CMAJ. 1994 Aug 1;151(3):325–330. [PMC free article] [PubMed] [Google Scholar]
  13. Schneider S. M., Thompson D. S. Repeat aborters. Am J Obstet Gynecol. 1976 Oct 1;126(3):316–320. doi: 10.1016/0002-9378(76)90542-1. [DOI] [PubMed] [Google Scholar]
  14. Spencer D. D., Robbins R. J., Naftolin F., Marek K. L., Vollmer T., Leranth C., Roth R. H., Price L. H., Gjedde A., Bunney B. S. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med. 1992 Nov 26;327(22):1541–1548. doi: 10.1056/NEJM199211263272201. [DOI] [PubMed] [Google Scholar]
  15. Strong C. Fetal tissue transplantation: can it be morally insulated from abortion? J Med Ethics. 1991 Jun;17(2):70–76. doi: 10.1136/jme.17.2.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Torres A., Forrest J. D. Why do women have abortions? Fam Plann Perspect. 1988 Jul-Aug;20(4):169–176. [PubMed] [Google Scholar]
  17. Widner H., Tetrud J., Rehncrona S., Snow B., Brundin P., Gustavii B., Björklund A., Lindvall O., Langston J. W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med. 1992 Nov 26;327(22):1556–1563. doi: 10.1056/NEJM199211263272203. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES